Translating GWAS Findings to Novel Therapeutic Targets for Coronary Artery Disease

  • Shu L
  • Blencowe M
  • Yang X
N/ACitations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

The success of genome-wide association studies (GWAS) has significantly advanced our understanding of the etiology of coronary artery disease (CAD) and opens new opportunities to reinvigorate the stalling CAD drug development. However, there exists remarkable disconnection between the CAD GWAS findings and commercialized drugs. While this could implicate major untapped translational and therapeutic potentials in CAD GWAS, it also brings forward extensive technical challenges. In this review we summarize the motivation to leverage GWAS for drug discovery, outline the critical bottlenecks in the field, and highlight several promising strategies such as functional genomics and network-based approaches to enhance the translational value of CAD GWAS findings in driving novel therapeutics.

Cite

CITATION STYLE

APA

Shu, L., Blencowe, M., & Yang, X. (2018). Translating GWAS Findings to Novel Therapeutic Targets for Coronary Artery Disease. Frontiers in Cardiovascular Medicine, 5. https://doi.org/10.3389/fcvm.2018.00056

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free